306 related articles for article (PubMed ID: 21782458)
21. Crystal structures of histone and p53 methyltransferase SmyD2 reveal a conformational flexibility of the autoinhibitory C-terminal domain.
Jiang Y; Sirinupong N; Brunzelle J; Yang Z
PLoS One; 2011; 6(6):e21640. PubMed ID: 21738746
[TBL] [Abstract][Full Text] [Related]
22. SMYD2-dependent HSP90 methylation promotes cancer cell proliferation by regulating the chaperone complex formation.
Hamamoto R; Toyokawa G; Nakakido M; Ueda K; Nakamura Y
Cancer Lett; 2014 Aug; 351(1):126-33. PubMed ID: 24880080
[TBL] [Abstract][Full Text] [Related]
23. A continuous protein methyltransferase (G9a) assay for enzyme activity measurement and inhibitor screening.
Dhayalan A; Dimitrova E; Rathert P; Jeltsch A
J Biomol Screen; 2009 Oct; 14(9):1129-33. PubMed ID: 19734436
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the Substrate Specificity of the SMYD2 Protein Lysine Methyltransferase and Discovery of Novel Non-Histone Substrates.
Weirich S; Schuhmacher MK; Kudithipudi S; Lungu C; Ferguson AD; Jeltsch A
Chembiochem; 2020 Jan; 21(1-2):256-264. PubMed ID: 31612581
[TBL] [Abstract][Full Text] [Related]
25. Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly.
Sampath SC; Marazzi I; Yap KL; Sampath SC; Krutchinsky AN; Mecklenbräuker I; Viale A; Rudensky E; Zhou MM; Chait BT; Tarakhovsky A
Mol Cell; 2007 Aug; 27(4):596-608. PubMed ID: 17707231
[TBL] [Abstract][Full Text] [Related]
26. Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput Screening.
Gradl S; Steuber H; Weiske J; Szewczyk MM; Schmees N; Siegel S; Stoeckigt D; Christ CD; Li F; Organ S; Abbey M; Kennedy S; Chau I; Trush V; Barsyte-Lovejoy D; Brown PJ; Vedadi M; Arrowsmith C; Husemann M; Badock V; Bauser M; Haegebarth A; Hartung IV; Stresemann C
SLAS Discov; 2021 Sep; 26(8):947-960. PubMed ID: 34154424
[TBL] [Abstract][Full Text] [Related]
27. Chemogenetic analysis of human protein methyltransferases.
Richon VM; Johnston D; Sneeringer CJ; Jin L; Majer CR; Elliston K; Jerva LF; Scott MP; Copeland RA
Chem Biol Drug Des; 2011 Aug; 78(2):199-210. PubMed ID: 21564555
[TBL] [Abstract][Full Text] [Related]
28. Structures of histone methyltransferase SET7/9 in complexes with adenosylmethionine derivatives.
Niwa H; Handa N; Tomabechi Y; Honda K; Toyama M; Ohsawa N; Shirouzu M; Kagechika H; Hirano T; Umehara T; Yokoyama S
Acta Crystallogr D Biol Crystallogr; 2013 Apr; 69(Pt 4):595-602. PubMed ID: 23519668
[TBL] [Abstract][Full Text] [Related]
29. Histone methyltransferase SMYD2: ubiquitous regulator of disease.
Yi X; Jiang XJ; Fang ZM
Clin Epigenetics; 2019 Aug; 11(1):112. PubMed ID: 31370883
[TBL] [Abstract][Full Text] [Related]
30. The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase.
Abu-Farha M; Lambert JP; Al-Madhoun AS; Elisma F; Skerjanc IS; Figeys D
Mol Cell Proteomics; 2008 Mar; 7(3):560-72. PubMed ID: 18065756
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma.
Yan L; Ding B; Liu H; Zhang Y; Zeng J; Hu J; Yao W; Yu G; An R; Chen Z; Ye Z; Xing J; Xiao K; Wu L; Xu H
Theranostics; 2019; 9(26):8377-8391. PubMed ID: 31754403
[TBL] [Abstract][Full Text] [Related]
32. The active site of the SET domain is constructed on a knot.
Jacobs SA; Harp JM; Devarakonda S; Kim Y; Rastinejad F; Khorasanizadeh S
Nat Struct Biol; 2002 Nov; 9(11):833-8. PubMed ID: 12389038
[TBL] [Abstract][Full Text] [Related]
33. An Integrative Proteomic Approach Identifies Novel Cellular SMYD2 Substrates.
Ahmed H; Duan S; Arrowsmith CH; Barsyte-Lovejoy D; Schapira M
J Proteome Res; 2016 Jun; 15(6):2052-9. PubMed ID: 27163177
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and structure-activity relationship studies of LLY-507 analogues as SMYD2 inhibitors.
Zhang B; Liao L; Wu F; Zhang F; Sun Z; Chen H; Luo C
Bioorg Med Chem Lett; 2020 Nov; 30(22):127598. PubMed ID: 33011288
[TBL] [Abstract][Full Text] [Related]
35. Histone-modifying enzymes: encrypting an enigmatic epigenetic code.
Couture JF; Trievel RC
Curr Opin Struct Biol; 2006 Dec; 16(6):753-60. PubMed ID: 17070031
[TBL] [Abstract][Full Text] [Related]
36. The N-terminus of Drosophila SU(VAR)3-9 mediates dimerization and regulates its methyltransferase activity.
Eskeland R; Czermin B; Boeke J; Bonaldi T; Regula JT; Imhof A
Biochemistry; 2004 Mar; 43(12):3740-9. PubMed ID: 15035645
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms for auto-inhibition and forced product release in glycine N-methyltransferase: crystal structures of wild-type, mutant R175K and S-adenosylhomocysteine-bound R175K enzymes.
Huang Y; Komoto J; Konishi K; Takata Y; Ogawa H; Gomi T; Fujioka M; Takusagawa F
J Mol Biol; 2000 Apr; 298(1):149-62. PubMed ID: 10756111
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of peptide-MCA substrates for a novel assay of histone methyltransferases and their inhibitors.
Chi H; Takemoto Y; Nsiama TK; Kato T; Nishino N; Ito A; Yoshida M
Bioorg Med Chem; 2014 Feb; 22(4):1268-75. PubMed ID: 24486204
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.
Komatsu S; Imoto I; Tsuda H; Kozaki KI; Muramatsu T; Shimada Y; Aiko S; Yoshizumi Y; Ichikawa D; Otsuji E; Inazawa J
Carcinogenesis; 2009 Jul; 30(7):1139-46. PubMed ID: 19423649
[TBL] [Abstract][Full Text] [Related]
40. Specificity of protein lysine methyltransferases and methods for detection of lysine methylation of non-histone proteins.
Rathert P; Dhayalan A; Ma H; Jeltsch A
Mol Biosyst; 2008 Dec; 4(12):1186-90. PubMed ID: 19396382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
